Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Lidocaine for Prevention of Postoperative Nausea and Vomiting
NCT04810494Phase 4Withdrawn
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Oct 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lidocaine 10% oropharyngeal spray in postoperative nausea and vomiting (PONV), sponsored by Penn State Health Milton S. Hershey Medical Center. Planned start Oct 2022; status: withdrawn.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT04810494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04810494.